欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6007/003
药品名称CONCERTA 54 mg Retardtabletten
活性成分
    • Methylphenidate hydrochloride 54.0 mg
剂型Prolonged-release tablet
上市许可持有人JANSSEN-CILAG GmbH Johnson & Johnson Platz 1 41470 Neuss Germany
参考成员国 - 产品名称Germany (DE)
CONCERTA 54 mg Retardtabletten
互认成员国 - 产品名称
    • Norway (NO)
    • Austria (AT)
      Concerta 54 mg Retardtabletten
    • Luxembourg (LU)
    • France (FR)
    • Greece (GR)
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Iceland (IS)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
    • Lithuania (LT)
      CONCERTA 54 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      CONCERTA
    • Cyprus (CY)
    • Romania (RO)
      CONCERTA 54 mg, comprimate filmate cu eliberare prelungită
    • Slovakia (SK)
      Concerta 54 mg tablety s predĺženým uvoľňovaním
    • Slovenia (SI)
    • Malta (MT)
    • Czechia (CZ)
许可日期2008/04/05
最近更新日期2025/07/16
药物ATC编码
    • N06BA04 methylphenidate
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase